Sign inJoin waitlistJoin the waitlist

Richard Furie

Chief, Division of Rheumatology and Allergy-Clinical Immunology, Northwell Health · Zucker School of Medicine at Hofstra/Northwell

Credentials: · · · ·

History

Division of Rheumatology and Allergy-Clinical Immunology · Zucker School of Medicine at Hofstra/Northwell
Present
Division of Rheumatology · Zucker School of Medicine at Hofstra/Northwell
Present
Zucker School of Medicine at Hofstra/Northwell
Present

Rheumatology
1982–1984
Internal Medicine
1979–1982
Cornell Univ Joan and Sanford I Weill Med Coll
1975–1979

Research

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial…
Arthritis & Rheumatism · 2006 · 1,313 citations
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Arthritis & Rheumatism · 2011 · First of 17 authors · Corresponding · 1,271 citations
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study
Arthritis & Rheumatism · 2012 · 1,098 citations

Kenneth Kalunian
37 papers
Michelle Petri
35 papers
JM
Joan Merrill
24 papers
Maria Dall'Era
24 papers
Jill Buyon
21 papers
DW
Daniel Wallace
20 papers
Brad Rovin
19 papers
Chaim Putterman
19 papers
Anca Askanase
18 papers
Betty Diamond
18 papers
Victoria Werth
18 papers
AD
Anne Davidson
17 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $3.4K · Feinstein Institute for Medical Research
2010–2011

Clinical trials

3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
Principal investigator · Terminated · Phase 1
Northwell Health
2016